Comprehensive analysis of prognostic value and immunotherapy prospect of brain cytoplasmic RNA1 in hepatocellular carcinoma

Figure 2 Association of brain cytoplasmic RNA1 expression with prognosis in hepatocellular carcinoma patients. A and B: Association of brain cytoplasmic RNA1 (BCYRN1) expression with overall survival (A) and disease-free survival (B) in hepatocellular carcinoma (HCC) patients in the GEPIA2 database; C and D: BCYRN1 expression in the Cancer Genome Atlas database in relation to overall survival (C) and progression-free (D) survival in HCC patients; E: Receiver operating characteristic curve to assess the predictive value of BCYRN1 expression with different prognostic years. AUC: Area under the curve; HR: Hazard ratio; TPM: Transcripts per million.